FET Clinical Trials

278 recruitingLast updated: July 25, 2026

There are 278 actively recruiting fet clinical trials across 57 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1. Top locations include New York, New York, United States, Barcelona, Spain, Madrid, Spain. Updated daily from ClinicalTrials.gov.


FET Trials at a Glance

278 actively recruiting trials for fet are listed on ClinicalTrialsFinder across 6 cities in 57 countries. The largest study group is Not Applicable with 94 trials, with the heaviest enrollment activity in New York, Barcelona, and Madrid. Lead sponsors running fet studies include Mỹ Đức Hospital, Regional Cardiology Center, The Copper Health Centre (MCZ),, and Assistance Publique - Hôpitaux de Paris.

Treatments under study

About FET Clinical Trials

Looking for clinical trials for FET? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new FET trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about FET clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 278 trials

Recruiting
Early Phase 1

A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

First in Man Study to Evaluate Initial SafetyOverweight and Obese AdultsHealthy Participants Study
Zealand Pharma88 enrolled1 locationNCT07721597
Recruiting

Placental Biology in Health and Disease

PregnancyPre-EclampsiaFetal Growth Restriction (FGR)+3 more
University of Oxford360 enrolled1 locationNCT07470320
Recruiting
Phase 1

Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With Asthma

Safety in Asthma Patients
Aspeya, Inc.40 enrolled3 locationsNCT07665892
Recruiting
Not Applicable

The Use of Virtual Reality Glasses in Women With Premature Rupture of Membranes

Prenatal AttachmentFetal Health AnxietyPrenatal Distress
Selcuk University176 enrolled1 locationNCT07660393
Recruiting
Not Applicable

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Attention Deficit Hyperactivity DisorderFetal Alcohol Spectrum Disorders
University of California, Los Angeles30 enrolled1 locationNCT06847165
Recruiting
Not Applicable

Analysis of Safety and Tissue Interaction of Injectable Biosmulators

This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers
Universitätsklinikum Hamburg-Eppendorf90 enrolled1 locationNCT06993558
Recruiting

Intraoperative Cognitive Load in Anesthesia Nurses Across Anesthetic Phases

PerformancePatient SafetyPerioperative+3 more
Hospital Clinic of Barcelona50 enrolled1 locationNCT07568158
Recruiting

Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device

Fetal Distress
Balgrist University Hospital20 enrolled2 locationsNCT06813859
Recruiting

Endometrial Peristalsis and Pregnancy Outcomes in Hormone Replacement Therapy (HRT) - Frozen Embryo Transfer (FET) Cycles

InfertilityFrozen Embryo Transfer (FET)Endometrial Peristalsis+4 more
Mỹ Đức Hospital442 enrolled1 locationNCT07675213
Recruiting

Placental Progesterone Membrane Receptors in Fetal Growth Restriction

PregnancyFetal Growth RestrictionPlacenta+4 more
Samsun University90 enrolled1 locationNCT07701837
Recruiting

Continuous Vital Sign Monitoring in a Surgical Ward

ImplementationWearable DevicesPatient Safety+7 more
University Hospital, Akershus9,600 enrolled1 locationNCT07690267
Recruiting
Phase 1

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Healthy VolunteerSafetyPharmacokinetics+2 more
Basilea Pharmaceutica96 enrolled1 locationNCT06733675
Recruiting
Phase 2

RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure

Fetal Alcohol Spectrum DisordersFetal Alcohol Syndrome
Wayne State University288 enrolled1 locationNCT04395196
Recruiting

A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells

Long Term Safety Following GM T Cell Therapy
Regeneron Pharmaceuticals50 enrolled1 locationNCT06798298
Recruiting
Phase 1

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines392 enrolled47 locationsNCT06427941
Recruiting

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

PregnancyFetal WeightMachine Learning+1 more
University of North Carolina, Chapel Hill1,000 enrolled5 locationsNCT07661433
Recruiting
Phase 3

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled62 locationsNCT05912517
Recruiting

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC175 enrolled14 locationsNCT07194070
Recruiting
Not Applicable

Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.

Efficacy and SafetyRuptured Aneurysm of Intracranial ArteryStent-Assisted Coiling
Tang-Du Hospital174 enrolled1 locationNCT07683377
Recruiting

Characterization of Fetal Lung With Quantitative Ultrasound

Respiratory ComplicationFetal Lung Imaging
University of Wisconsin, Madison16 enrolled1 locationNCT06722365